deltatrials
Active Not Recruiting OBSERVATIONAL NCT02051114

Discovering the Antecedents of Rheumatoid Arthritis Flare

Sponsor: Rockefeller University

Updated 19 times since 2017 Last updated: Apr 15, 2026 Started: Feb 1, 2014 Primary completion: Feb 1, 2030 Completion: Feb 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02051114, this observational or N/A phase trial focuses on Rheumatoid Arthritis and remains ongoing. Sponsored by Rockefeller University, it has been updated 19 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Study Description(click to expand)

80% of patients living with rheumatoid arthritis can expect fluctuations in their symptoms over time. Dramatic increases in disease activity are considered flare. This study will follow patients with increased risk for flare prospectively for one year. Serial questionnaires and disease activity scores will be compared to blood samples to better understand the molecular phenotype of rheumatoid arthritis flares.

80% of patients living with rheumatoid arthritis can expect fluctuations in their symptoms over time. Dramatic increases in disease activity are considered flare. This study will follow patients with increased risk for flare prospectively for one year. Serial questionnaires and disease activity scores will be compared to blood samples to better understand the molecular phenotype of rheumatoid arthritis flares.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Feb 2020 · 13 months · monthly snapshot~Feb 2020 – ~Jun 2020 · 4 months · monthly snapshot~Jun 2020 – ~Nov 2020 · 5 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Dec 2021 · 8 months · monthly snapshot~Dec 2021 – ~May 2022 · 5 months · monthly snapshot~May 2022 – ~May 2023 · 12 months · monthly snapshot~May 2023 – ~May 2024 · 12 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – ~Apr 2026 · 13 months · monthly snapshotApr 17, 2026 – present · 5 months · daily API

Change History

19 versions recorded
  1. Apr 17, 2026 — Present [daily]

    Active Not Recruiting

  2. Apr 2025 — Apr 2026 [monthly]

    Active Not Recruiting

  3. Sep 2024 — Apr 2025 [monthly]

    Active Not Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  5. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting

Show 14 earlier versions
  1. May 2023 — May 2024 [monthly]

    Active Not Recruiting

  2. May 2022 — May 2023 [monthly]

    Active Not Recruiting

  3. Dec 2021 — May 2022 [monthly]

    Active Not Recruiting

  4. Apr 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  5. Jan 2021 — Apr 2021 [monthly]

    Active Not Recruiting

  6. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  7. Jun 2020 — Nov 2020 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  8. Feb 2020 — Jun 2020 [monthly]

    Recruiting

  9. Jan 2019 — Feb 2020 [monthly]

    Recruiting

  10. Jun 2018 — Jan 2019 [monthly]

    Recruiting

  11. May 2018 — Jun 2018 [monthly]

    Recruiting

  12. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  13. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  14. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

Longitudinal study of patients with rheumatoid arthritis comparing measures of disease activity with blood samples.

Contact Information

Sponsor contact:
  • Rockefeller University
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations